- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
NUBEQA - - 112
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L02BB06 | B | Darolutamide - 300mg | 10645 | 126320/1 | NUBEQA | 112 | Tablet, film coated | Oral | Droguerie R. Pharaon & Fils S.A.L. | Orion Corporation Orion Pharma | Finland | 439,365,472 L.L | 2.44 | E2 | Bayer AG | Germany | 2/5/2024 | 0 |